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Abstract
Bronchiolitis is the most common lower respiratory tract infections in infants. It is time to reach a unique clinical definition, 
encompassing the acute onset of respiratory distress with cough, tachypnoea, retraction and diffuse crackles on auscultation in 
infants aged less than 12 months. 
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Acute bronchiolitis is the most common lower respiratory tract infection 
in infants less than 12 months of age, and it is the leading cause of 
hospitalisation in this age group, particularly in infants younger than 
six months. It is mainly caused by respiratory syncytial virus (RSV) and 
shows a seasonal pattern, with peak incidence occurring during winter, 
but other respiratory viruses can often be involved.1 Particularly, infants 
with RSV bronchiolitis are younger, have been breastfed for a shorter 
time and have a more severe form of bronchiolitis with prevalent chest 
X-ray findings of diffuse air trapping, whereas, human Rhinovirus (hRV), 
the second most frequent virus involved, seems to cause a milder 
form of bronchiolitis and affecting infants with a higher eosinophils 
count and, possibly, with an atopic predisposition.1 Each year 150 
million new cases of bronchiolitis are reported worldwide with an 
increasing trend in medical visits and total hospitalisations along with 
the diagnosis of bronchiolitis. 
Despite the fact that bronchiolitis is an ‘old’ disease, several aspects are 
still debated. First, a clear definition of this entity is still lacking. According 
to the European definition, bronchiolitis is a clinical diagnosis requiring 
epidemiological data, such as the epidemic period (December to March), 
the age of infants and the specific clinical appearance (signs of an upper 
respiratory infection: runny nose, fever, chough, followed by respiratory 
distress with diffuse crackles on auscultation).2 On the contrary, the 
American Pediatric Academy defines bronchiolitis as the first episode of 
acute viral wheeze occurring in infants less than two years old. It is evident 
that this definition likely overlaps the early presentation of wheezing or 
bronchial hyper-responsiveness.3 To exclude infants with virus-associated 
episodes of wheezing, we should consider bronchiolitis only in infants 
younger than 12 months presenting with their first episode of lower 
respiratory infection, who had diffuse crackles on auscultation.4 Wheezing 
is a high-pitched, musical, adventitious lung sound produced by turbulent 
airflow through a narrowed airway, whereas crackles are caused by the 
‘popping open’ of small airways and alveoli collapsed by fluid, thus possibly 
reflecting two different entities affecting two different lung structures.
Second, it is a self-limiting disease and it should be managed only with 
supportive care. Reduced feeding is common and very young infants 
may present with apnoeic episodes, thus leading to hospitalisation, 
which is required by 2–3% of infants affected.5 Some patients, 
particularly when risk factors are present, can manifest a severe 
disease and the admission to the intensive care unit may be required. 
Few predisposing factors may explain the clinical worsening, leading to 
paediatric intensive care unit admission for ventilatory support. Young 
age (under one month), possibly due to the small size of the airways, and 
RSV carriage are the most important demographic factors associated 
with severe respiratory distress that is uncommon in previously healthy 
term infants and often develops soon after disease onset.
Furthermore, the conflict that exists in the definition creates many 
problems, especially in the interpretation of results of clinical trials and 
the relationship between bronchiolitis and wheezing and asthma. A single 
definition of bronchiolitis will allow an analysis of the homogeneous 
disease pathogenesis and the possible role of new therapeutic 
strategies. The exclusive use of supportive treatments (nasal washing, O2 
and hydration) is restricted for pure bronchiolitis infants. In fact, bubbly 
nasopharyngeal secretions, by obstructing the nostrils may cause 
transient decreases in SpO2 in infants that are obligate nasal breathers. 
On the other hand, several medical therapies might be useful in wheezing 
children 12–24 months old. For example, the use of bronchodilators, as 
well as of corticosteroids, is no longer recommended for bronchiolitis 
infants, but may play a role in wheezing children. Overlapping these 
two diagnoses could result in erroneous management of children with 
respiratory failure. Nowadays, there is a huge variability in the clinical 
management of this disease around the world, including widespread use 
of unnecessary tests and ineffective therapies.
Moreover, long-standing evidence underlines the role of bronchiolitis 
in the occurrence of subsequent wheezing and asthma, especially in 
infants with hRV infection and a high eosinophils count during the 
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disease.6 The use of asthma controller medication in children after 
hospitalisation for bronchiolitis is equally high with increasing health 
costs. Host and viral factors actively interact during respiratory 
infections, but it is still debated whether the virus directly modifies 
the host immune response or it simply identifies infants somehow 
prone to wheeze.
Recent evidence suggests that the age limit should be further restricted 
to six months because the clinical entity seems to even differ over this 
age in terms of aetiology, clinical severity and possibly pathogenesis.4 
It remains to be determined whether the clinical manifestations 
of bronchiolitis differ in children younger than six months or if it is a 
separate disease.
In conclusion, we believe that bronchiolitis needs to reach a unique 
definition, characterised by acute onset of respiratory distress with 
cough, tachypnoea, retraction and diffuse crackles on auscultation in 
infants less than 12 months, or even six months of age. ■
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